{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-089008","form_type":"8-K","ticker":"OGN","cik":"0001821825","company_name":"Organon & Co.","filed_at":"2026-07-31T12:23:43+00:00","discovered_at":"2026-07-31T12:25:00.217087+00:00","generated_at":"2026-07-31T12:25:05.555979+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"low","headline":"Organon furnishes supplemental non-GAAP Q2 2026 metrics; merger with Sun Pharma pending","bullets":["Company released Q2 2026 financial results via Form 10-Q, not a press release, due to pending merger with Sun Pharmaceutical Industries.","Supplemental non-GAAP metrics for Q2 2026 are furnished in Exhibit 99.1 but no specific figures are provided in the filing text.","Customary earnings press release and conference call suspended for the quarter.","Non-GAAP measures are intended to supplement GAAP results; full GAAP disclosures are in the 10-Q filed July 31, 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-089008","json":"https://secwatch.observer/filing/0001104659-26-089008.json","markdown":"https://secwatch.observer/filing/0001104659-26-089008.md","text":"https://secwatch.observer/filing/0001104659-26-089008.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1821825/000110465926089008/0001104659-26-089008-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1821825/000110465926089008/tm2621744d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-31T12:25:05.555979+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}